Zacks Research cut shares of Option Care Health (NASDAQ:OPCH – Free Report) from a hold rating to a strong sell rating in a research report released on Monday,Zacks.com reports.
Several other equities research analysts have also issued reports on OPCH. Jefferies Financial Group reaffirmed a “buy” rating and set a $37.00 price target on shares of Option Care Health in a research note on Tuesday, January 13th. Morgan Stanley set a $28.00 price target on Option Care Health in a research note on Wednesday, May 6th. UBS Group dropped their price target on Option Care Health from $45.00 to $39.00 and set a “buy” rating for the company in a research note on Friday, May 1st. JPMorgan Chase & Co. dropped their price target on Option Care Health from $40.00 to $33.00 and set an “overweight” rating for the company in a research note on Monday, May 4th. Finally, Wall Street Zen lowered Option Care Health from a “buy” rating to a “hold” rating in a research note on Saturday, February 28th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, three have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Option Care Health presently has a consensus rating of “Moderate Buy” and an average target price of $31.25.
Get Our Latest Analysis on OPCH
Option Care Health Price Performance
Option Care Health (NASDAQ:OPCH – Get Free Report) last posted its quarterly earnings data on Thursday, April 30th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.03. The company had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.39 billion. Option Care Health had a return on equity of 18.17% and a net margin of 3.64%.The firm’s quarterly revenue was up 1.3% on a year-over-year basis. During the same quarter last year, the company earned $0.40 earnings per share. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. On average, research analysts expect that Option Care Health will post 1.64 EPS for the current fiscal year.
Insider Buying and Selling at Option Care Health
In other Option Care Health news, CEO John Charles Rademacher purchased 12,500 shares of the stock in a transaction on Monday, May 4th. The stock was acquired at an average price of $21.18 per share, with a total value of $264,750.00. Following the transaction, the chief executive officer directly owned 695,152 shares of the company’s stock, valued at approximately $14,723,319.36. This trade represents a 1.83% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Timothy P. Sullivan purchased 24,154 shares of the stock in a transaction on Thursday, May 7th. The shares were acquired at an average cost of $20.69 per share, with a total value of $499,746.26. Following the transaction, the director directly owned 73,383 shares in the company, valued at $1,518,294.27. The trade was a 49.06% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders acquired 73,264 shares of company stock valued at $1,548,316 in the last 90 days. Insiders own 1.70% of the company’s stock.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently made changes to their positions in the company. Durable Capital Partners LP boosted its position in shares of Option Care Health by 134.2% in the 2nd quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company’s stock worth $267,557,000 after purchasing an additional 4,720,988 shares in the last quarter. Southpoint Capital Advisors LP bought a new stake in shares of Option Care Health in the 4th quarter worth approximately $95,580,000. Sumitomo Mitsui Trust Group Inc. bought a new stake in shares of Option Care Health in the 1st quarter worth approximately $70,287,000. Norges Bank bought a new stake in shares of Option Care Health in the 4th quarter worth approximately $61,787,000. Finally, Van Berkom & Associates Inc. bought a new stake in shares of Option Care Health in the 1st quarter worth approximately $42,739,000. Hedge funds and other institutional investors own 98.05% of the company’s stock.
About Option Care Health
Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.
Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.
Read More
- Five stocks we like better than Option Care Health
- Navy Catalyst Ignites Odysight’s Growth Engine
- AST SpaceMobile Plummets on Galactic Q1 Miss: Can Vertical Integration Save the SpaceX Rival?
- Axon Surged After Earnings and Is Still Down Over 50% From Highs
- The Event That Could Redefine Apple’s Summer Rally
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.
